Psychotic Disorders: all 1,655 studies

Page 5 of 17. Open to participants first (298), then studies with results posted, then the rest; newest registration first within each.

• Testing the Effectiveness of The Welcome Basket InterventionCompletedNCT02946255Not applicableResults posted
• Assessment of Intra-subject Variability in the Bioavailability of Chlorpromazine HydrochlorideCompletedNCT02943213Phase 1Results posted
• Pentosan Polysulfate Sodium and Meclofenamic Acid as Treatments in Patients With Psychotic DisordersCompletedNCT02930005Phase 2Results posted
• Remediation of Auditory Recognition in Schizophrenia With tDCSCompletedNCT02869334Not applicableResults posted
• A Study of Tolerability and Efficacy of Cannabidiol on Tremor in Parkinson's DiseaseCompletedNCT02818777Phase 2Results posted
• Lifestyle Intervention for Young Adults With Serious Mental IllnessCompletedNCT02815813Not applicableResults posted
• Sulforaphane to Reduce Symptoms of SchizophreniaCompletedNCT02810964Phase 2Results posted
• MEtformin and Lorcaserin for WeighT Loss in SchizophreniaTerminatedNCT02796144Phase 4Results posted
• Comparative Effectiveness of Adaptive Treatment Strategies for SchizophreniaCompletedNCT02775864Results posted
• Transcranial Brain Stimulation and Its Underlying Neural Mechanisms as a Novel Treatment for Auditory HallucinationsCompletedNCT02769507Not applicableResults posted
• Aspirin in Young Psychotic PatientsCompletedNCT02685748Phase 2/3Results posted
• Skills Training to Enhance Vocational Outcomes in Veterans With Serious Mental IllnessCompletedNCT02663349Not applicableResults posted
• Study in Stabilized Schizophrenic Patients to Evaluate the Pharmacokinetics of Risperidone and 9-Hydroxy (OH)-Risperidone When Risperidone is Administered From a Polyurethane ImplantCompletedNCT02658357Phase 2Results posted
• Targeting Cerebellum to Treat Psychosis: a Transcranial Magnetic Stimulation (TMS) StudyCompletedNCT02642029Not applicableResults posted
• Clinical Medication Development for Bipolar Disorder and Alcohol Use DisordersCompletedNCT02582905Phase 4Results posted
• CBT-I for Psychosis: Guidelines, Preliminary Efficacy, and Functional OutcomesCompletedNCT02535923Not applicableResults posted
• Cannabidiol Treatment in Patients With Early PsychosisCompletedNCT02504151Phase 2Results posted
• Improving Adherence to Cognitive RehabilitationCompletedNCT02481713Not applicableResults posted
• A Study to Assess the Clinical Utility of Antipsychotic Medication Levels in Plasma as Determined by Liquid Chromatography-Tandem Mass SpectrometryTerminatedNCT02462473Phase 2Results posted
• A Study to Compare Disease Progression and Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics in Participant's With Recent-onset Schizophrenia or SchizophreniformCompletedNCT02431702Phase 3Results posted
• Exenatide Weekly Injections as an Adjunctive Treatment in Patients With SchizophreniaCompletedNCT02417142Phase 4Results posted
• Supported Employment in Patient Aligned Care TeamsCompletedNCT02400736Not applicableResults posted
• Motivational Negative Symptoms in Schizophrenia: Intervention and BiomarkersCompletedNCT02386605Not applicableResults posted
• STimulation to Improve Auditory haLLucinationsCompletedNCT02360228Not applicableResults posted
• Fluoxetine vs Aripiprazole Comparative Trial (FACT)TerminatedNCT02357849Phase 4Results posted
• Effect of MMFS-202-302 on Cognitive Enhancement in SchizophreniaCompletedNCT02237235Phase 2Results posted
• Galantamine and Memantine Combination for Cognitive Impairments in SchizophreniaTerminatedNCT02234752Phase 2Results posted
• Lurasidone Effects on Tissue Glutamate in SchizophreniaCompletedNCT02199743Phase 4Results posted
• Fixed Dose Intervention Trial of New England Enhancing Survival in SMI PatientsCompletedNCT02188121Phase 4Results posted
• Exercise and Markers of Medial Temporal Health in Youth At-risk for PsychosisCompletedNCT02155699Not applicableResults posted
• Effects of Metformin and Fish Oil on Treatment With ClozapineTerminatedNCT02140788Phase 4Results posted
• rTMS in First Episode PsychosisCompletedNCT02131129Not applicableResults posted
• Treatment of Psychosis and Agitation in Alzheimer's DiseaseCompletedNCT02129348Phase 2Results posted
• Minocycline Augmentation to ClozapineCompletedNCT02124811Phase 4Results posted
• Curcumin as a Novel Treatment to Improve Cognitive Dysfunction in SchizophreniaCompletedNCT02104752Phase 1/2Results posted
• A Concierge Model of CAE Plus LAI in Individuals With Schizophrenia at Risk for Treatment Non-adherence and HomelessnessCompletedNCT02085447Not applicableResults posted
• Transcranial Direct Current Stimulation and Cognitive Remediation Therapy for PsychosisCompletedNCT02085421Not applicableResults posted
• Nicotinic Enhancement of Cognitive Remediation Training in SchizophreniaCompletedNCT02069392Not applicableResults posted
• A Study of the Safety and Efficacy of Pimavanserin in Patients With Alzheimer's Disease PsychosisCompletedNCT02035553Phase 2Results posted
• Tocilizumab as Add-On Treatment For Residual Positive, Negative, and Cognitive Symptoms of SchizophreniaCompletedNCT02034474Phase 4Results posted
• Biomarkers in First Episode SchizophreniaCompletedNCT02033382Results posted
• Comparison of E-health vs. In-person Multi-Family Group (MFG)CompletedNCT02032680Not applicableResults posted
• A Study of GWP42003 as Adjunctive Therapy in the First Line Treatment of Schizophrenia or Related Psychotic DisorderCompletedNCT02006628Phase 2Results posted
• Building Employment Skills Through Therapy for VeteransCompletedNCT01992913Not applicableResults posted
• Targeted Self-Management for Epilepsy and Serious Mental Illness (TIME)CompletedNCT01992393Not applicableResults posted
• D-Cycloserine Augmentation of Cognitive Behavioral Therapy for DelusionsCompletedNCT01981759Phase 4Results posted
• Acceptance and Commitment Therapy for the Inpatient Treatment of PsychosisCompletedNCT01981356Early Phase 1Results posted
• Development of a Mobile System for Self-management of Schizophrenia (SOS)CompletedNCT01969500Not applicableResults posted
• Cannabis, Schizophrenia and Reward: Self-Medication and Agonist Treatment?CompletedNCT01964404Phase 1Results posted
• Transcranial Current Stimulation as a Treatment for Auditory Hallucinations in SchizophreniaCompletedNCT01963676Not applicableResults posted
• A New Paradigm for Illness Monitoring and Relapse Prevention in SchizophreniaCompletedNCT01952041Not applicableResults posted
• Personalized and Scalable Cognitive Remediation ApproachesCompletedNCT01945333Not applicableResults posted
• Assessing the Effects of Fanapt® on Social Cognition in SchizophreniaTerminatedNCT01929889Phase 4Results posted
• Cognitive Behavior Therapy for Work Success in Veterans With Mental Illness: A Pre-post Efficacy StudyCompletedNCT01918774Not applicableResults posted
• Antipsychotic Effects on Brain Function in SchizophreniaTerminatedNCT01913327Phase 4Results posted
• Get Moving and Get Well - Pilot StudyCompletedNCT01884025Not applicableResults posted
• Monitoring and Management for Metabolic Side Effects of AntipsychoticsCompletedNCT01875861Not applicableResults posted
• Naltrexone for Antipsychotic-Induced Weight GainCompletedNCT01866098Not applicableResults posted
• An Efficacy and Safety Study of Risperidone Long-Acting Microspheres in Participants With Schizophrenia, Schizophreniform or Schizoaffective DisordersCompletedNCT01855074Phase 4Results posted
• The Family VOICE StudyCompletedNCT01804582Not applicableResults posted
• Withania Somnifera: an Immunomodulator and Anti-inflammatory Agent for SchizophreniaCompletedNCT01793935Not applicableResults posted
• Omega-3 Dietary Supplements in SchizophreniaCompletedNCT01786239Not applicableResults posted
• Helping Those With Mental Illness Quit SmokingCompletedNCT01783912Phase 4Results posted
• Decision Support for Smoking Cessation in Young Adults With Severe Mental IllnessCompletedNCT01779440Not applicableResults posted
• The Family Cognitive Adaptation Training Manual: A Test of EffectivenessCompletedNCT01768000Not applicableResults posted
• Oxytocin and CBSST for People With SchizophreniaCompletedNCT01752712Not applicableResults posted
• Probiotics to Prevent Relapse After Hospitalization for ManiaCompletedNCT01731171Not applicableResults posted
• Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and AdolescentsCompletedNCT01731119Phase 2Results posted
• Neurobiology of a Mutation in Glycine Metabolism in Psychotic DisordersCompletedNCT01720316Phase 2Results posted
• Kuvan in People With Schizophrenia and Schizoaffective DisorderCompletedNCT01706965Phase 1/2Results posted
• NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)CompletedNCT01688037Phase 2Results posted
• PACT for Individuals With Serious Mental IllnessCompletedNCT01668355Not applicableResults posted
• Evaluating Isradipine for Cognitive Enhancement in Schizophrenia and Schizoaffective DisorderCompletedNCT01658150Not applicableResults posted
• Acute Glycine Pharmacodynamic StudyCompletedNCT01610011Not applicableResults posted
• Psychosis: Early Detection, Intervention and PreventionCompletedNCT01597141Not applicableResults posted
• Salsalate as an Adjunctive Treatment for Patients With SchizophreniaCompletedNCT01578486Phase 4Results posted
• Safety, Tolerability, and Pharmacokinetic Study of EVP-6124 in Patients With SchizophreniaCompletedNCT01556763Phase 1Results posted
• PTSD (PostTraumatic Stress Disorder) Services for Veterans With SMI (Severe Mental Illness)CompletedNCT01542229Not applicableResults posted
• Cognitive Training for Patients With SchizophreniaCompletedNCT01521026Not applicableResults posted
• Effectiveness of Cognitive Remediation in a Supported Education SettingCompletedNCT01492439Not applicableResults posted
• RP5063 in Subjects With Schizophrenia or Schizoaffective DisorderCompletedNCT01490086Phase 2Results posted
• Life Goals Collaborative Care to Improve Health Outcomes in Mental DisordersCompletedNCT01487668Not applicableResults posted
• Treatment to Enhance Cognition in Bipolar DisorderCompletedNCT01470781Not applicableResults posted
• NAPLS Omega-3 Fatty Acid Versus Placebo StudyCompletedNCT01429454Phase 1Results posted
• Sustaining Remission of Psychotic DepressionCompletedNCT01427608Phase 4Results posted
• Trial to Evaluate the Effects of OPC-34712 on QT/QTc in Subjects With Schizophrenia or Schizoaffective DisorderCompletedNCT01423916Phase 1Results posted
• Improving Outcomes for Individuals With Serious Mental Illness and DiabetesCompletedNCT01410357Not applicableResults posted
• Nicotinic Receptors and SchizophreniaCompletedNCT01400477Phase 2Results posted
• NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective DisorderCompletedNCT01393600Phase 2Results posted
• N-Acetyl-Cysteine (NAC) in Early Phase Schizophrenia Spectrum PsychosisCompletedNCT01354132Phase 2Results posted
• Addiction Housing Case Management for Homeless VeteransCompletedNCT01346514Not applicableResults posted
• The Effect of N-Acetyl Cysteine on Cortical Erosion in Early Stage SchizophreniaCompletedNCT01339858Phase 4Results posted
• An Integrated Program for the Treatment of First Episode of PsychosisCompletedNCT01321177Not applicableResults posted
• Second-Generation Antipsychotic Treatment Indication Effectiveness And Tolerability In Youth (Satiety) StudyCompletedNCT01269710Results posted
• Social Cognition InterventionCompletedNCT01267019Not applicableResults posted
• Reducing Internalized Stigma in People With Serious Mental IllnessCompletedNCT01259427Phase 2Results posted
• Double-Blind Trial of a Probiotic Supplement to Reduce the Symptoms of SchizophreniaCompletedNCT01242371Not applicableResults posted
• Yoga and Aerobic Exercise in PsychosisCompletedNCT01207219Not applicableResults posted
• A Study to Evaluate the Efficacy of Paliperidone Palmitate in the Prevention of Relapse of the Symptoms of Schizoaffective DisorderCompletedNCT01193153Phase 3Results posted
• A Study of the Safety and Efficacy of Pimavanserin in Patients With Parkinson's Disease PsychosisCompletedNCT01174004Phase 3Results posted

← Psychotic Disorders overview